Randomized Study Comparing Pre- and Postoperative vs. Conventional Adjuvant Treatment in Receptor-negative Patients

NCT00309569 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

429

Enrollment

NETWORK

Sponsor class

Conditions

Early Stage Breast Cancer

Interventions

DRUG: Cyclophosphamide
DRUG: Methotrexate
DRUG: Fluorouracil
DRUG: Epirubicin
OTHER: Surgery

Sponsor

Austrian Breast & Colorectal Cancer Study Group